CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
14 hedge funds and large institutions have $106K invested in COSCIENS Biopharma Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
92% less call options, than puts
Call options by funds: $45K | Put options by funds: $536K
Holders
14
Holding in Top 10
–
Calls
$45K
Puts
$536K
Top Buyers
| 1 | +$29.8K | |
| 2 | +$5.92K | |
| 3 | +$1.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$258 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$180 |
Top Sellers
| 1 | -$521 | |
| 2 | -$330 | |
| 3 | -$99 | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$90 |
| 5 |
IGWM
ICA Group Wealth Management
Denver,
Colorado
|
-$3 |